ANTIVIRAL THERAPY FOR FACIAL NEUROPATHY ASSOCIATED WITH HERPES SIMPLEX VIRUS TYPE 1
- Autores: Ruzhentsova T.A.1, Khavkina D.A.2, Chukhlyaev P.V.2
-
Afiliações:
- Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- «REAVIZ» Moscow Medical University
- Edição: Nº 5 (2017)
- Páginas: 56-60
- Seção: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/278674
- ID: 278674
Citar
Texto integral
![Acesso aberto](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Previous investigations have shown the value of herpes simplex virus 1 (HSV-1) in the development of nervous system lesions. Lesions of cranial nerves occur in patients of any age and substantially disrupt a patient’s ability to work and quality of life. Facial neuropathy (Bell’s palsy) is most common. This disease is characterized by the high rate of detection of HSV-1 markers and by the efficiency of antiviral therapy. However, the high prevalence of HSV-1 infection in the population, including also among healthy individuals cannot be viewed as convincing evidence for the role of the virus in the development of Bell’s palsy. The paper gives a clinical example of Bell’s palsy developing in a 27-year-old female patient with an exacerbation of HSV-1-induced infection. The treatment with anti-inflammatory and neurotropic drugs in combination with microcirculation-improving agents and non-drug therapy were ineffective. Lower-grade fever, facial asymmetry complaints, and headache persisted after a cycle of treatment. Blood tests showed lymphocytosis and the higher titers of IgM and IgG antibodies to HSV-1. The use of acyclovir resulted in the relief of symptoms.
Palavras-chave
Texto integral
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
Tatiana Ruzhentsova
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: ruzhencova@gmail.com
МD, Leading Researcher, Clinical Department of Infectious Pathology 3a, Novogireevskaya St., Moscow 111123, Russia
Daria Khavkina
«REAVIZ» Moscow Medical University
Email: havkina@gmail.com
Six-Year Student, Faculty of General Medicine
Pavel Chukhlyaev
«REAVIZ» Moscow Medical University
Email: pafachka@gmail.com
Six-Year Student, Faculty of General Medicine
Bibliografia
- Исаков В.А., ред. Герпесвирусные инфекции человека: руководство для врачей. СПб.: СпецЛит, 2013. 670 с.
- Михайлова И.И., Орлова В.А., Минутко В.Л., Малышева И.Н., Елисеева Н.А., Холодняк А.Ю., Кретова Ж.Ю. Сопряженность психопатологической симптоматики и уровня сывороточных антител к вирусам группы герпеса при различных типах течения приступообразной шизофрении. Академический журнал Западной Сибири 2013; 6(49): 99-102.
- Prasad K.M., Eack S.M., Goradia D., Pancholi K.M., Keshavan M.S., Yolken R.H., Nimgaonkar V.L. Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. Am. J. Psychiatry 2011; 168(8): 822-30. D0I:10.1176/appi.ajp.2011.10101423.
- Shirts B.H., Prasad K.M., Pogue-Geile M.F., Dickerson F, Yolken R.H., Nimgaonkar V.L. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophrenia Research 2008; 106(2-3): 268-74. D0I:10.1016/j.schres.2008.07.017.
- Свистушкин В.М., Славский А.Н. Невропатия лицевого нерва: современные подходы к диагностике и лечению. Русский медицинский журнал 2016; (4): 280-5.
- Невропатия лицевого нерва. В кн.: Одинака М.М., ред. Частная неврология: учебное пособие. М.: МИА, 2009: 110-4.
- Baringer J.R., Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N. Engl. J. Med. 1973; 288: 648-50. D0I:10.1056/nejm197303292881303.
- Grundfest-Broniatowski S., Broniatowski M., Davies C.R., Jacobs C.B., Tucker H.M., Nose Y. Fine control ofreinnervated muscle. Dynamic rehabilitation of facial paralysis. ASAIO 1989; 35(3): 484-6. D0I:10.1097/00002480-198907000- 00101.
- Yanagihara N. Facial nerve paralysis and its viral etiology. Asian Med. J. 1998; 41(2): 72-6.
- Furuta Y., Takasu T., Sato K.C., Fukuda S., Inuyama Y., Nagashima K. Latent herpes simplex virus type 1 in human geniculate ganglia. Acta Neuropathologica 1992; 84: 39-4. D0I:10.1007/bf00427213.
- McCormick D.P. Herpes-simplex virus as cause of Bell’s palsy. Lancet 1972; 299(7757): 937-9. D0I:10.1016/s0140-6736(72)91499-7.
- Sartoretti-Schefer S., Wichmann W., Valavanis A. Idiopathic, herpetic and HIV-associated facial nerve palsies: abnormal MR enhancement patterns. Am. J. Neuroradiol. 1994; 15: 479-85.
- Johnson R.T., Griffin J.W. eds. Current therapy in Neurologic Disease. 5th ed. St. Louis: Mosby, 1997. 429 p.
- Деконенко Е.П., Леонтьева И.Я., Мартыненко И.Н., Митрофанова И.В., Соколова М.В., Караванов А.С., Прыткова М.И., Соколова М.М., Идрисова Ж.Р. Невриты лицевого нерва и их связь с вирусами герпеса. Журнал неврологии и психиатрии 2000; (6): 58-9.
- Adour K.K., Ruboyianes J.M., Von Doersten P.G., Quesenberry C.P., Byl F.M., Hitchcock T. Bell’s palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol. Rhin. Laryng. 1996; 105(5): 371-8. D0I:10.1177/000348949610500508.
Arquivos suplementares
![](/img/style/loading.gif)